Skip to main content

This translation is provided for general access and has no recorded medical-language review.

Editorial general information — not a clinical-review record

Published: Updated: Publisher: Dr. Murat Toktamışoğlu

How should HIFU, filler and botulinum toxin be sequenced in one plan?

There is no single universal order for HIFU, filler and botulinum toxin on the same or nearby dates. Overlapping anatomy, the device's target depth, filler material and location, the toxin's target muscle, emergency monitoring and the ability to attribute an outcome all need to be planned together.

This translation has no recorded clinical or medical-language review.

Direct answer

  • Laxity, volume and muscle activity are different targets and each requires a separate indication.
  • Combination publications are mostly small, retrospective or based on expert consensus.
  • Same-day convenience should not displace anatomical sequencing and follow-up needs.

Separate the targets first

HIFU directs controlled ultrasound energy to selected tissue depths; filler places material in tissue; botulinum toxin temporarily reduces neuromuscular transmission in selected muscles. Not every visible facial change has the same mechanism. Examination should identify which finding is being addressed by which tool and for what limited purpose; an all-face package is not a substitute for medical reasoning.

Why does sequence vary by person?

The energy layer may overlap the position of previously placed filler, while oedema and tenderness can obscure assessment of a later procedure. Toxin effect and filler volume emerge on different timelines from HIFU-related remodelling. Retrospective combination data may show no obvious safety signal, but cannot exclude rare events or establish the ideal interval for every product and device.

A written plan and follow-up

Record the product or device identity, area, target, reason for sequence, expected timeline and urgent-contact instructions separately for every procedure. Staging interventions may make it easier to understand what produced a change when outcome attribution matters. An active complication, unidentified old filler, recent surgery or unexplained finding calls for diagnosis and record verification before a combination plan.

Scope of this article

This content is not diagnosis, prescribing, personal risk assessment or a treatment plan. Sources may be limited to a particular product, device, task, indication or study group.

Sources and evidence limits

These links are editorial starting points used to examine the article's boundaries.

  1. A Systematic Review of the Efficacy of Microfocused Ultrasound for Facial Skin Tightening

    Contini M, Hollander MHJ, Vissink A, Schepers RH, Jansma J, Schortinghuis J · 2023

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review

  2. A Systematic Review and Meta-Analysis of the Clinical Efficacy and Patients' Satisfaction of Micro-Focused Ultrasound Treatment for Facial Rejuvenation and Tightening

    Ling J, Zhao H · 2023

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review

  3. Update on Absorbable Facial Thread Lifts

    Riopelle AM, Geisler AN, Eber A, Dover JS · 2025

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review

  4. A Meta-Analysis and Systematic Review of the Incidences of Complications Following Facial Thread-Lifting

    Niu Z et al. · 2021

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review

  5. Dermal Fillers (Soft Tissue Fillers)

    U.S. Food and Drug Administration (FDA) · 2023

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review

  6. Guideline for the Management of Hyaluronic Acid Filler-Induced Vascular Occlusion

    Gillian Murray, Cormac Convery, Lee Walker, Emma Davies; Complications in Medical Aesthetics Collaborative (CMAC) · 2021

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review

  7. Safety and Potential Complications of Facial Wrinkle Correction with Dermal Fillers: A Systematic Literature Review

    Audra Janovskiene, Deividas Chomicius, Dominykas Afanasjevas, Zygimantas Petronis, Dainius Razukevicius, Egle Jagelaviciene · 2024

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review

  8. BOTOX Cosmetic (onabotulinumtoxinA) Prescribing Information

    U.S. Food and Drug Administration (FDA) · 2024

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review

  9. Cosmetic Botulinum Toxin A Injections to the Upper Face: A Systematic Review and Meta-Analysis of Clinical Studies

    Alaa Safia, Uday Abd Elhadi, Shlomo Merchavy, Ramzy Batheesh, Naji Bathish · 2026

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review

  10. Complications of Cosmetic Botulinum Toxin A Injections to the Upper Face: A Systematic Review and Meta-Analysis

    David Zargaran, Florence Zoller, Alexander Zargaran, Eqram Rahman, Alexander Woollard, Tim Weyrich, Afshin Mosahebi · 2022

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review

  11. Combining Microfocused Ultrasound With Botulinum Toxin and Temporary and Semi-Permanent Dermal Fillers

    S. G. Fabi et al. · 2016

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review

  12. Consensus Recommendations for Combined Aesthetic Interventions Using Botulinum Toxin, Fillers, and Microfocused Ultrasound

    S. G. Fabi et al. · 2016

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review